Azilsartan Kamedoxomil; Chlorthalidone Patent Expiration
Azilsartan Kamedoxomil; Chlorthalidone is Used for managing high blood pressure. It was first introduced by Azurity Pharmaceuticals Inc
Azilsartan Kamedoxomil; Chlorthalidone Patents
Given below is the list of patents protecting Azilsartan Kamedoxomil; Chlorthalidone, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Edarbyclor | US9387249 | Methods of treating hypertension with at least one angiotensin II receptor blocker and chlorthalidone | Jul 01, 2031 | Azurity |
| Edarbyclor | US9169238 | Solid pharmaceutical composition | Feb 04, 2030 | Azurity |
| Edarbyclor | US9066936 | Solid pharmaceutical composition comprising a benzimidazole-7-carboxylate derivative and a pH control agent | Mar 26, 2028 | Azurity |
| Edarbyclor | US7157584 | Benzimidazole derivative and use thereof | May 22, 2025 | Azurity |
| Edarbyclor | US7572920 | Benzimidazole derivative and use as a II receptor antagonist |
Jan 07, 2025
(Expired) | Azurity |
| Edarbyclor | US5583141 | Heterocyclic compounds and their use as angiotensin antagonists |
Dec 10, 2013
(Expired) | Azurity |
Azilsartan Kamedoxomil; Chlorthalidone's Family Patents
Explore Our Curated Drug Screens
Azilsartan Kamedoxomil; Chlorthalidone Generic API Manufacturers
Several generic applications have been filed for Azilsartan Kamedoxomil; Chlorthalidone.
Given below is the list of companies who have filed for Azilsartan Kamedoxomil; Chlorthalidone generic, along with the locations of their manufacturing plants worldwide.
1. ALKEM LABS LTD
Alkem Laboratories Ltd has filed for 2 different strengths of generic version for Azilsartan Kamedoxomil; Chlorthalidone. All of these versions come by the name AZILSARTAN MEDOXOMIL AND CHLORTHALIDONE. Given below are the details of the strengths of this generic introduced by Alkem Labs Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 40MG MEDOXOMIL; 12.5MG | tablet | Prescription | ORAL | AB | Jan 21, 2025 |
| EQ 40MG MEDOXOMIL; 25MG | tablet | Prescription | ORAL | AB | Jan 21, 2025 |